152 related articles for article (PubMed ID: 21542562)
1. Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activity.
Fytas C; Zoidis G; Tzoutzas N; Taylor MC; Fytas G; Kelly JM
J Med Chem; 2011 Jul; 54(14):5250-4. PubMed ID: 21542562
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic conformationally constrained spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: An extended SAR study.
Zoidis G; Tsotinis A; Tsatsaroni A; Taylor MC; Kelly JM; Efstathiou A; Smirlis D; Fytas G
Chem Biol Drug Des; 2018 Feb; 91(2):408-421. PubMed ID: 28834291
[TBL] [Abstract][Full Text] [Related]
3. Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-
Fytas G; Zoidis G; Taylor MC; Kelly JM; Tsatsaroni A; Tsotinis A
Future Med Chem; 2019 Jun; 11(11):1259-1266. PubMed ID: 31161793
[No Abstract] [Full Text] [Related]
4. Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2013 Nov; 21(21):6600-7. PubMed ID: 24012457
[TBL] [Abstract][Full Text] [Related]
5. Convenient Synthesis of Alternatively Bridged Tryptophan Ketopiperazines and Their Activities against Trypanosomatid Parasites.
Cockram PE; Turner CA; Slawin AMZ; Smith TK
ChemMedChem; 2022 Feb; 17(4):e202100664. PubMed ID: 34927802
[TBL] [Abstract][Full Text] [Related]
6. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
[TBL] [Abstract][Full Text] [Related]
7. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
8. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.
Kelly JM; Taylor MC; Horn D; Loza E; Kalvinsh I; Björkling F
Bioorg Med Chem Lett; 2012 Mar; 22(5):1886-90. PubMed ID: 22326398
[TBL] [Abstract][Full Text] [Related]
11. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
[TBL] [Abstract][Full Text] [Related]
13. Trypanocidal activity of a new series of arsenical compounds the spiroarsorans.
Loiseau P; Bories C; Gayral P; Wolf JG
Farmaco Sci; 1988; 43(7-8):657-63. PubMed ID: 3224710
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands.
Rivas F; Del Mármol C; Scalese G; Pérez Díaz L; Machado I; Blacque O; Salazar F; Coitiño EL; Benítez D; Medeiros A; Comini M; Gambino D
Inorg Chem; 2024 Jun; 63(25):11667-11687. PubMed ID: 38860314
[TBL] [Abstract][Full Text] [Related]
15. Stereospecific synthesis of chiral 2,3-dihydro-1,4-benzodithiine and methyl-2,3-dihydro-1,4-benzodithiine derivatives and their toxic effects on Trypanosoma brucei.
Ali Shah ST; Merkel P; Ragge H; Duszenko M; Rademann J; Voelter W
Chembiochem; 2005 Aug; 6(8):1438-41. PubMed ID: 16052614
[TBL] [Abstract][Full Text] [Related]
16. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
17. Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease.
de Menezes Dda R; Calvet CM; Rodrigues GC; de Souza Pereira MC; Almeida IR; de Aguiar AP; Supuran CT; Vermelho AB
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):964-73. PubMed ID: 26327246
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
19. 8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
Fersing C; Boudot C; Castera-Ducros C; Pinault E; Hutter S; Paoli-Lombardo R; Primas N; Pedron J; Seguy L; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Brossas JY; Paris L; Valentin A; Wyllie S; Fairlamb AH; Boutet-Robinet É; Corvaisier S; Since M; Malzert-Fréon A; Destere A; Mazier D; Rathelot P; Courtioux B; Azas N; Verhaeghe P; Vanelle P
Eur J Med Chem; 2020 Sep; 202():112558. PubMed ID: 32652409
[TBL] [Abstract][Full Text] [Related]
20. 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.
Rahmani R; Ban K; Jones AJ; Ferrins L; Ganame D; Sykes ML; Avery VM; White KL; Ryan E; Kaiser M; Charman SA; Baell JB
J Med Chem; 2015 Sep; 58(17):6753-65. PubMed ID: 26247439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
